Nicole Boczek, Ph.D., explains the innovative new hereditary hearing loss panel now available through Mayo Clinic Laboratories. This comprehensive panel analyzes 160 genes associated with hereditary hearing loss, assessing for both nonsyndromic hearing loss, as well as syndromic hearing loss, which can be difficult to recognize clinically.
Show Notes
(
00:48)
Could you provide our listeners with a little bit about you and your background?
(
01:56)
There's a fair amount of genetic hearing loss tests out there. Why did we decide to develop this one here at Mayo?
(
02:51)
Can you tell me a little bit about the process that actually went into developing the test — the different research and that sort of thing?
(
04:03)
What specific need do we meet with this particular test?
(
06:22)
How were these results used in patient care? And what I mean by that is, when you're talking about the downstream management of the patient, what are some of the different treatments that can result from the use of this test?
(
08:16)
How does our test compare to some of these tests that are out there right now?
(
09:48)
Where in the patient's journey would this test be used? I know it's a diagnostic test and not a screening test, but could you expand on that a little more for me?
What is Answers from the Lab?
A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.